Acupuncture Aids Outcomes After Heart Valve Surgery
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 27, 2023 -- Acupuncture after heart valve surgery is feasible and safe and has clinical benefit, according to a study recently published in JTCVS Open.
Kim L. Feingold, Ph.D., from Northwestern University Feinberg School of Medicine in Chicago, and colleagues randomly assigned (1:1) patients undergoing primary valve surgery via sternotomy to acupuncture (51 individuals) or standard care (49 individuals). Daily inpatient acupuncture sessions started on postoperative day 1.
The researchers found that an average of 3.8 acupuncture sessions were delivered per patient during a mean hospital stay of 4.6 days. Acupuncture was associated with lower pain, nausea, stress, and anxiety after each session and across admission versus standard care. Additionally, acupuncture was associated with a lower incidence of postoperative atrial fibrillation (acupuncture, 13.7 percent; standard care, 32.7 percent), fewer discharges on amiodarone (acupuncture, 9.8 percent; standard care, 26.5 percent), and fewer hours in the intensive care unit (acupuncture, 30.3; standard care, 37.0).
"We learned that acupuncture after open heart surgery is feasible in this fast-paced environment -- even in the intensive care unit the day after surgery -- and was well tolerated by patients with no adverse effects," Feingold said in a statement. "The majority of patients had no prior history with acupuncture, demonstrating their openness to receive integrative therapies after surgery. Overall, patients reported that it was a pleasant and positive aspect of their cardiovascular surgery recovery."
Several authors disclosed ties to the medical technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
Ulcerative Hunner Lesions Can Help Characterize Bladder Pain, Infection
TUESDAY, July 2, 2024 -- Distinct phenotypic and urine biological characteristics are seen for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with a history of...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.